Assyro AI

FDA Orange Book · active-ingredient family

Benzoyl peroxide; tretinoin

Benzoyl peroxide; tretinoin is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:TWYNEO · NDA 214902

1

Brand (NDA)

0

Generics (ANDA)

13

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream

ProductApplicantApplicationTEApproved
TWYNEORLDMAYNE PHARMANDA 214902Jul 26, 2021

Listed patents (13)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8617580Feb 03, 2028in 1 yr 8 mo
Product
12156946Feb 03, 2028in 1 yr 8 mo
Product
9868103Aug 08, 2028in 2 yr 2 mo
ProductU-3194
10653899Dec 30, 2030in 4 yr 7 mo
ProductU-3194
12070629Dec 30, 2030in 4 yr 7 mo
ProductU-3987
11071878Dec 30, 2030in 4 yr 7 mo
Product
12053546Jun 29, 2032in 6 yr 1 mo
Product
12357602Jul 12, 2038in 12 yr 3 mo
ProductU-3987
10420743Jul 12, 2038in 12 yr 3 mo
U-3194
12295935Dec 27, 2040in 14 yr 9 mo
U-3987
12257348May 23, 2041in 15 yr 2 mo
ProductU-3987
12491163May 23, 2041in 15 yr 2 mo
ProductU-3987
12133919May 23, 2041in 15 yr 2 mo
ProductU-3987

Benzoyl peroxide; tretinoin — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.